Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 4, 1996, Pages 496-501

  Bader, D ^a   Blondheim, O ^a   Jonas, R ^a   Admoni, O ^a   Abend Winger, M ^a   Reich, D ^a   Lanir, A ^a   Tamir, A ^a   Eldar, I ^a   Attias, D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anaemia; Erythropoietin; Ferritin; Iron; Preterm

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9244233348     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14070.x     Document Type: Article

References (13)

1. Phibbs RH, Shannon KM, Mentzer NC. Potential for treatment of anemia of prematurity with recombinant human erythropoietin: Preliminary results. Acta Haematol 1992;87 Suppl 1: 28-33
2. Rhondeau SM, Christensen RO, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity". J Pediatr 1988;112:935-40
3. Brach MA, Herrmann F. Haematopoietic growth factors: Interactions and regulation of production. Acta Haematol 1991;86:128-37
4. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98-102
5. Halperin DS, Wacker P, Lancourt G, Felix M, Babel JF, Aapro M et al. Effects of recombinant human erythropoietin in infants with anemia of prematurity, a pilot study. J Pediatr 1990;116: 779-86
6. Obladen M, Segere MR. Efficacy and safety of recombinant human erythropoietin to prevent the anemia of prematurity. Contrib Nephrol 1991;88:314-26
7. Shannon KM, Mentzer WC, Ables RI. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo controlled pilot study. J Pediatr 1991;118:949-55
8. Messer J, Addad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatr 1993;92:519-23
9. Floss AM, Strauss RG, Goeken N, Ox L. Multiple transfusions fail to provoke antibodies against blood cell antigen in human infants. Transfusion 1986;26:419-22
10. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epotin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994;330:1173-8
11. Ohls RK, Christensen RD. Recombinant human erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991;119:781-8
12. Soubasi V, Kremenopoulas G, Diamandi E, Tsantali C, Tsakivi D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study. Pediatr Res 1993;34:675-9
13. Bechensteen AG, Haga P, Halvorsen S. Erythropoietin, protein and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993;69:19-23